CAIX Inhibitor DTP348

Known as: 2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethylsulfamide, DTP348 
An orally bioavailable, nitroimidazole-based sulfamide, carbonic anhydrase IX (CAIX) inhibitor with potential antineoplastic activity. Upon… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2010-2017
01220102017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Although radiotherapy remains the most powerful as well as the primary treatment modality for nasopharyngeal carcinoma (NPC… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2015
2015
Triple negative, resistant or metastatic disease are major factors in breast cancer mortality, warranting novel approaches… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2015
2015
Karim Chamie and colleagues report in Urologic Oncology an analysis of carbonic anhydrase IX (CAIX) staining from kidney tumours… (More)
Is this relevant?
2011
2011
As hypoxia is believed to play an important role in the development and progression of prostate cancer, we evaluated whether 18F… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2010
2010
We have studied lactic acid transport in the fast mouse extensor digitorum longus muscles (EDL) by intracellular and cell surface… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?